Modifications in nasal function and nitric oxide serum level in type 1 diabetes

Journal of Otolaryngology - Head and Neck Surgery

Volumn 37, Issue 5, 2008, Pages 611-615

  Nardo, Walter Di ^a   Pitocco, Dario ^a   Leo, Mauro A S Di ^a   Picciotti, Pasqualina M ^a   Stasio, Enrico Di ^a   Collina, Chiara ^a   Santini, Stefano ^a   Scarano, Emanuele ^a   Ghirlanda, Giovanni ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Diabetes; Nitric oxide; Rhinomanometry

Indexed keywords

NITRIC OXIDE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; NOSE AIRWAY RESISTANCE; NOSE MUCOSA; OLFACTORY SYSTEM; PRIORITY JOURNAL; RHINOMANOMETRY;

ADULT; AIRWAY RESISTANCE; BLOOD GLUCOSE; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 1; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; NASAL CAVITY; NASAL MUCOSA; NASAL OBSTRUCTION; NITRIC OXIDE; PROBABILITY; REFERENCE VALUES; RHINOMANOMETRY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 64349099977     PISSN: 19160216     EISSN: None     Source Type: Journal    
DOI: 10.2310/7070.2008.0075     Document Type: Article

References (18)

1. Siperstein MD, Unger RH, Madison LL. Studies of muscle capillary basement membranes in normal subjects, diabetic, and prediabetic patients. J Clin Invest 1968;47:1973-99.
2. Eichler HG, Blaschke TF, Kraemer FB, et al. Responsiveness of superficial hand veins to alpha-adrenoceptor agonists in insulin-dependent diabetic patients. Clin Sci (Lond) 1992;82:163-8.
3. Vinik AI, Erbas T. Recognizing and treating diabetic autonomic neuropathy. Clin J Med 2001;68:928-44.
4. Muller M, Betlejewski S. Nasal mucosa in patients with diabetes mellitus. Otolaryngol Pol 2003;57:361-4.
5. Bachmann W, Konig WF. Panorama-mask suited for rhinomanometry. HNO 1970;18:21-2.
6. Clement PA. Committee report on standardization of rhinoma-nometry. Rhinology 1984;22:151-5.
7. Hirschberg A. Rhinomanometry: an update. ORL J Otorhino-laryngol Relat Spec 2002;64:263-7.
8. Young MJ, Every N, Boulton AJ. A comparison of the neurothe-siometer and biothesiometer for measuring vibration perception in diabetic patients. Diabetes Res Clin Pract 1993;20:129-31.
9. Ewing DJ, Clarke BF. Diagnosis and management of diabetic autonomic neuropathy. Br Med J (Clin Res Ed) 1982;285:916-8.
10. Veves A, Young MJ, Manes C, et al. Differences in peripheral and autonomic nerve function measurements in painful and painless neuropathy. A clinical study. Diabetes Care 1994;17:1200-2.
11. th I.S.I.A.N. (International Symposium of Infection & allergy of the nose). Athen 1986;102:791-2.
12. Yue WL. Nasal mucociliary clearance in patients with diabetes mellitus. J Laryngol Otol 1989;103:853-5.
13. Loth S, Loth A, Bende M. Nasal mucosal blood flow in patients with diabetes mellitus. J Laryngol Otol 1988;102:791-2.
14. Di Nardo W, Ghirlanda G, Paludetti G, et al. Distortion-product otoacoustic emissions and selective sensorineural loss in IDDM. Diabetes Care 1998;21:1317-21.
15. Di Leo MA, Di Nardo W, Cercone S, et al. Cochlear dysfunction in IDDM patients with subclinical peripheral neuropathy. Diabetes Care 1997;20:824-8.
16. Di Nardo W, Ghirlanda G, Cercone S, et al. The use of dynamic posturography to detect neurosensorial disorder in IDDM without clinical neuropathy. J Diabetes Complications 1999;13:79-85.
17. Santini SA, Marra G, Giardina B, et al. Defective plasma antioxidant defenses and enhanced susceptibility to lipid peroxidation in uncomplicated IDDM. Diabetes 1997;46:1853-8.
18. Motamed M, Sandhu D, Murty GE. Sildenafil and nasal obstruction. J Otolaryngol 2003;32:259-61.